Latest News
Novartis Gains Rights To Debio 025
Novartis has gained rights to develop and market Debio 025 (alisporivir), a potential first-in-class antiviral agent, currently in phase IIb development for the treatment of hepatitis C. Debio 025 has...
Published: 09-Feb-2010
Alliance Pharma To Acquire Cambridge Laboratories
Alliance Pharma has conditionally agreed to acquire Cambridge Laboratories (Ireland) and Cambridge Laboratories (together the 'Vendors'), for total consideration of between £14.3m and £16.4m, plus the...
Published: 08-Feb-2010
AnaptysBio Seals Pact With Merck
AnaptysBio has entered into a strategic collaboration with Merck & Co, through an affiliate, to develop novel antibody therapeutics for a specified disease target. ...
Published: 08-Feb-2010
Merz Launches Denzapine In Ireland
Merz Pharma (Merz) has launched Denzapine, generic version of Clozapine in Ireland. Clozapine is an antipsychotic medication. The product is available in the UK since February 2004, reported medical n...
Published: 07-Feb-2010
DxS Enters Pact With Pfizer
Pfizer and DxS, a wholly owned subsidiary of Qiagen have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the...
Published: 05-Feb-2010
BioMarin To Take Over LEAD Therapeutics
BioMarin has entered into a stock purchase agreement to acquire LEAD Therapeutics, a drug discovery and early stage development company with key compound, LT-673, an orally available poly (ADP-ribose)...
Published: 05-Feb-2010
GSK Names New President Of GSK Japan
GlaxoSmithKline (GSK) has appointed Philippe Fauchet as president of GSK Japan. Mr Fauchet will report to Marc Dunoyer, who takes the new role as chairman of GSK Japan. Mr Dunoyer will continue to tak...
Published: 04-Feb-2010
Ipsen, Debiopharm Launch Cancer Drug In France
Ipsen and its partner, Debiopharm, have launched Decapeptyl LP 22.5mg, a sustained release drug for treatment of locally-advanced or metastatic hormone-dependent prostate cancer, in France. The compan...
Published: 04-Feb-2010
Mintaka Foundation for Medical Research Receives £2.7m For HIV Research
The Mintaka Foundation for Medical Research in Geneva has received fund of £2.7m from Wellcome Trust, London. The fund will be used to proceed an anti-HIV microbicide known as 5P12-RANTES, to clinical...
Published: 04-Feb-2010
Pfizer Q4 Net Income Increases 188%
Pfizer has reported financial results for fourth-quarter and full-year 2009. Fourth-quarter 2009 revenues were $16.5 billion, an increase of 34% compared to $12.3 billion in the year-ago quarter. For ...
Published: 04-Feb-2010
Free Newsletter Sign-up
Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750
Browse A-Z
Tecnosoft
Monitoring Systems for Temperature, Humidity and Pressure ...
Vetter Pharma International
High-Quality Aseptically Pre-Filled Injection Systems, Cartridges and Vials ...
Lomapharm
Your Competent Partner for Solid and Liquid Pharmaceuticals ...
LyondellBasell
Polyolefins for Healthcare Applications ...
Investigator Location Services
Instant Access to Experienced Investigators ...
Turku Region
A Bright Future in a Great Location ...
Browse A-Z
GRACO's New FDA Pumps
The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...
GRACO's New Hydra-Clean
The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...
GRACO's New 1590 & 3150 Pumps
The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...
Water Treatment
From the control room to the downstream processing area and with an eye on utilities servi ...
Customer Testimonial – Astra Zeneca
From the control room to the downstream processing area and with an eye on utilities servi ...
Hygienic Processing
From the control room to the downstream processing area and with an eye on utilities servi ...

